---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-085545"
form_type: "8-K"
ticker: "XOMA"
cik: "0000791908"
company_name: "XOMA Royalty Corp"
filed_at: "2024-04-03T23:59:59+00:00"
generated_at: "2026-06-04T03:06:38.661852+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# XOMA completes acquisition of Kinnate Biopharma for $2.5879 per share plus CVRs

## Summary
- XOMA purchased ~81% of Kinnate shares via tender offer at $2.5879/share plus one CVR per share.
- Merger closed under DGCL Section 251(h); remaining shares converted to same consideration.
- CVRs entitle holders to potential payments from future disposition of Kinnate's products within one year, up to five years.
- Total of 38,258,681 shares tendered; all conditions satisfied for merger.
- XOMA expects to realize value from Kinnate's pipeline; CVR agreement filed as exhibit.

## SEC filing metadata
- accession: 0001193125-24-085545
- form_type: 8-K
- ticker: XOMA
- cik: 0000791908
- company_name: XOMA Royalty Corp
- filed_at: 2024-04-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/791908/000119312524085545/0001193125-24-085545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/791908/000119312524085545/d793644d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-085545
- JSON: https://secwatch.observer/filing/0001193125-24-085545.json
- Plain text: https://secwatch.observer/filing/0001193125-24-085545.txt

## Key facts
- M&A Transactions
  XOMA Royalty Corp completed an acquisition involving Kinnate Biopharma Inc. for $2.5879 in cash per Share plus one non-transferable contractual contingent value right per Share (closed 2024-04-03).
  - Action: acquisition
  - Counterparty: Kinnate Biopharma Inc.
  - Consideration: $2.5879 in cash per Share plus one non-transferable contractual contingent value right per Share
  - Closing: 2024-04-03
  source text: April 3, 2024, XOMA completed a tender offer to purchase all of Kinnate’s outstanding shares of common stock, par value $0.0001 per share (the “ Shares ”), in exchange for (i) $2.5879 in cash per Share (the “ Cash Amount ”), plus (ii) one non-transferable contractual contingent value right per Share (each, a “ CVR ” and each CVR together with the Cash Amount,
  evidence_url: https://www.sec.gov/Archives/edgar/data/791908/000119312524085545/0001193125-24-085545-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.